[go: up one dir, main page]

MX2020011280A - Proceso para la hidrolisis de esteres carboxilicos de quinolona. - Google Patents

Proceso para la hidrolisis de esteres carboxilicos de quinolona.

Info

Publication number
MX2020011280A
MX2020011280A MX2020011280A MX2020011280A MX2020011280A MX 2020011280 A MX2020011280 A MX 2020011280A MX 2020011280 A MX2020011280 A MX 2020011280A MX 2020011280 A MX2020011280 A MX 2020011280A MX 2020011280 A MX2020011280 A MX 2020011280A
Authority
MX
Mexico
Prior art keywords
quinolone carboxylic
mol
carboxylic esters
hydrolysis
formula
Prior art date
Application number
MX2020011280A
Other languages
English (en)
Inventor
Peter Fey
Mathias Berwe
Jörg Wirths
Ralf Wischnat
Markus Longerich
Antje Dietzel
Original Assignee
Bayer Animal Health Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Animal Health Gmbh filed Critical Bayer Animal Health Gmbh
Publication of MX2020011280A publication Critical patent/MX2020011280A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Health & Medical Sciences (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Quinoline Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Los ésteres del ácido carboxílico de quinolona la fórmula general (II) se hidrolizan para dar ácidos quinoloncarboxílicos la fórmula general (I): (ver Fórmulas) El procedimiento comprende la etapa A): A) Reacción de compuestos de fórmula (II) con una mezcla que contiene ácido acético, ácido sulfúrico y agua En la etapa A) se utilizan por mol compuestos de la fórmula (II) = 30 a = 40 mol de ácido acético, = 0.3 a = 1 mol de ácido sulfúrico y = 0,9 a = 2.5 mol de agua. El procedimiento es particularmente adecuado para la síntesis del intermedio (I) en la síntesis de pradofloxacina.
MX2020011280A 2018-04-25 2019-04-18 Proceso para la hidrolisis de esteres carboxilicos de quinolona. MX2020011280A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP18169170 2018-04-25
PCT/EP2019/060072 WO2019206798A1 (de) 2018-04-25 2019-04-18 Verfahren zur hydrolyse von chinoloncarbonsäureestern

Publications (1)

Publication Number Publication Date
MX2020011280A true MX2020011280A (es) 2020-11-13

Family

ID=62063375

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020011280A MX2020011280A (es) 2018-04-25 2019-04-18 Proceso para la hidrolisis de esteres carboxilicos de quinolona.

Country Status (23)

Country Link
US (1) US11332444B2 (es)
EP (1) EP3784656B1 (es)
JP (1) JP7410050B2 (es)
KR (1) KR102727204B1 (es)
CN (1) CN111989314B (es)
AU (1) AU2019260015C1 (es)
CA (1) CA3098060A1 (es)
CL (1) CL2020002735A1 (es)
CO (1) CO2020013343A2 (es)
CR (1) CR20200502A (es)
DK (1) DK3784656T3 (es)
DO (1) DOP2020000189A (es)
ES (1) ES2956316T3 (es)
IL (1) IL278175A (es)
MX (1) MX2020011280A (es)
MY (1) MY204213A (es)
PE (1) PE20201257A1 (es)
PH (1) PH12020551750A1 (es)
PT (1) PT3784656T (es)
SG (1) SG11202010544TA (es)
TW (1) TW202003470A (es)
UY (1) UY38201A (es)
WO (1) WO2019206798A1 (es)

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3420798A1 (de) 1984-06-04 1985-12-05 Bayer Ag, 5090 Leverkusen 7-(3-aryl-l-piperazinyl)- sowie 7-(3-cyclohexyl-l-piperazinyl)-3-chinoloncarbonsaeuren
DE3702393A1 (de) 1987-01-28 1988-08-11 Bayer Ag 8-cyano-1-cyclopropyl-1,4-dihydro-4-oxo- 3-chinolincarbonsaeuren, verfahren zu ihrer herstellung und diese enthaltende antibakterielle mittel
SK284542B6 (sk) 1996-02-23 2005-06-02 Bayer Healthcare Ag Prípadne substituované 8-kyán-1-cyklopropyl-7-(2,8-diazabicyklo- [4,3,0]-nonán-8-yl)-6-fluór-1,4-dihydro-4-oxo-3- chinolínkarboxylové kyseliny a ich deriváty, spôsob ich výroby a ich použitie ako liečiv
DE19652239A1 (de) * 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
CN1338455A (zh) * 2000-08-16 2002-03-06 大连绿源实业有限公司 新的喹诺酮羧酸的制备方法
DE10108750A1 (de) 2001-02-23 2002-09-05 Bayer Ag Verbessertes Verfahren zur Herstellung von Fluorchinoloncarbonsäuren
DE10134719A1 (de) 2001-07-17 2003-02-06 Bayer Ag Pharmazeutische Zubereitungen enthaltend wirkstoffbeladene Ionentauscherharze
DE10224086A1 (de) 2002-05-31 2003-12-11 Bayer Ag Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker
US6900224B2 (en) * 2002-07-31 2005-05-31 The Procter & Gamble Company Antimicrobial quinolones, their compositions and uses
DE10312346A1 (de) 2003-03-20 2004-09-30 Bayer Healthcare Ag Kontrolliertes Freisetzungssystem
DE10337191A1 (de) 2003-08-13 2005-03-17 Bayer Healthcare Ag Neue Verwendung von Chinolon-Antibiotika
DE10351448A1 (de) 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
DE102005055385A1 (de) 2004-12-09 2006-06-14 Bayer Healthcare Ag Arzneimittel zur hygienischen Applikation im Ohr
CN105622632B (zh) * 2014-10-29 2018-06-29 浙江海森药业股份有限公司 一种喹诺酮类化合物及其制备方法

Also Published As

Publication number Publication date
KR20210005079A (ko) 2021-01-13
DOP2020000189A (es) 2020-11-30
JP7410050B2 (ja) 2024-01-09
MY204213A (en) 2024-08-16
AU2019260015B2 (en) 2024-07-11
DK3784656T3 (da) 2023-09-18
ES2956316T3 (es) 2023-12-19
CL2020002735A1 (es) 2021-02-26
US11332444B2 (en) 2022-05-17
EP3784656B1 (de) 2023-06-28
PE20201257A1 (es) 2020-11-16
PT3784656T (pt) 2023-09-22
EP3784656A1 (de) 2021-03-03
CN111989314B (zh) 2024-04-30
CA3098060A1 (en) 2019-10-31
WO2019206798A1 (de) 2019-10-31
AU2019260015A1 (en) 2020-12-17
US20210078950A1 (en) 2021-03-18
TW202003470A (zh) 2020-01-16
IL278175A (en) 2020-11-30
AU2019260015C1 (en) 2024-11-21
KR102727204B1 (ko) 2024-11-06
CO2020013343A2 (es) 2020-10-30
PH12020551750A1 (en) 2021-07-26
CR20200502A (es) 2020-12-22
JP2021521238A (ja) 2021-08-26
CN111989314A (zh) 2020-11-24
BR112020021635A2 (pt) 2021-01-26
SG11202010544TA (en) 2020-11-27
UY38201A (es) 2019-11-29

Similar Documents

Publication Publication Date Title
FI20125879A7 (fi) Menetelmä ligniinin esteröimiseksi ainakin yhden rasvahapon avulla
IN2014CN02971A (es)
ATE512994T1 (de) Hocheffizientes verfahren zur herstellung von polyalkylenoxidcarbonsäuren
TW200602305A (en) Process for preparing alpha-hydroxy carboxylic acids and esters thereof
GEP20217217B (en) Industrial process for the preparation of cariprazine
MX2018004148A (es) Acetato de celulosa y metodo y dispositivo para producir acetato de celulosa.
SG178578A1 (en) Preparation of acetic acid
EP2665705A4 (en) PROCESS FOR THE IMPROVED PREPARATION OF SUCCINIMIDE COMPLEXES OF MOLYBDENUM OF LOW MOLECULAR WEIGHT
ATE409693T1 (de) Verfahren zur herstellung von 2-(4- chlorbenzoylamino-3- 2(1h)-chinolinon-4-yl propionsäure
MX2020011280A (es) Proceso para la hidrolisis de esteres carboxilicos de quinolona.
MX354498B (es) Cristal de hidrato 5-hidroxi-1h-imidazol-4-carboxamida-3/4, metodo para producir el mismo y cristal de hidrato de 5-hidroxi-1h-imidazol-4-carboxamida.
ATE473979T1 (de) Verfahren zur herstellung von abacavir
MX2020005544A (es) Metodo para preparar acetato de salicilamina.
CN103483386A (zh) 一种改进的1-丙基磷酸环酐的制备方法
MX2012000278A (es) Procedimiento para la preparacion de acidos (2,4-dimetilbifenil-3- il)aceticos, sus esteres, asi como compuestos intermedios.
WO2011095872A8 (fr) Procede de preparation d'un ester d'acide carboxylique
MX2022010709A (es) Proceso para la preparacion de amidas y carboxilatos del acido 5-cloro-3-alquilsulfanilo-piridina-2-carboxilico.
BR112022016929A2 (pt) Um método de produção de uma forma cristalina de tri-hidrato de 2-[(4s)-8-fluoro-2-[4-(3-metoxifenil)piperazin-1-il]-3-[2-metoxi-5-(trifluorometil)fenil]-4h-quinazolin-4-il]acetato de sódio
HU0200692D0 (en) Improved process for preparing fluoro-substituted quinolone carboxylic acids
MX2021008768A (es) Metodo para la produccion de acido 4-ciano benzoico o sus sales.
CN104628550B (zh) 一种一氯醋酸制备方法
MX2021001530A (es) Metodo de produccion de esteres carbonicos.
FR2974084B1 (fr) Procede de fabrication de phtalate de dialkyle
PH22020050345U1 (en) An Improved Hydrolysis Process
UA78469U (uk) СПОСІБ ОДЕРЖАННЯ ЗАМІЩЕНИХ 4,4а,5,7,7а,8-ГЕКСАГІДРОФУРО[2,3-f]ІЗОБЕНЗОФУРАН-4-КАРБОНОВИХ КИСЛОТ